1
Jul
2019
List of USFDA approved Biosimilar [till date]
Click here to view the list.
USFDA approved Biosimilars
US approval | Year of Approval | Biosilimar Brand | Company | Biomolecule | Reference Product |
---|---|---|---|---|---|
1 | 2015 | Zarxio | Amgen | Filgrastim | Neupogen |
2 | 2016 | Inflectra | Janssen Biotech | Infliximab | Remicade |
3 | 2016 | Erelzi | Amgen | Etanercept | Enbrel |
4 | 2016 | Amjevita | AbbVie | Adalimumab | Humira |
5 | 2017 | Renflexis | Amgen | Infliximab | Remicade |
6 | 2017 | Cyltezo | AbbVie | Adalimumab | Humira |
7 | 2017 | Mvasi | Roche | Bevacizumab | Avastin |
8 | 2017 | Ogivri | Roche | Trastuzumab | Herceptin |
9 | 2017 | Ixifi | Amgen | Infliximab | Remicade |
10 | 2018 | Retacrit | Amgen (Epogen) / Procrit (Janssen Biotech) | Epoetin alfa | Epogen/Procrit |
11 | 2018 | Fulphila | Amgen | Pegfilgrastim | Neulasta |
12 | 2018 | Nivestym | Amgen | Filgrastim | Neupogen |
13 | 2018 | Hyrimoz | AbbVie | Adalimumab | Humira |
14 | 2018 | Udenyca | Amgen | Pegfilgrastim | Neulasta |
15 | 2018 | Truxima | Roche | Rituximab | Rituxan |
16 | 2018 | Herzuma | Roche | Trastuzumab | Herceptin |
17 | 2019 | Ontruzant | Roche | Trastuzumab | Herceptin |
18 | 2019 | Trazimera | Roche | Trastuzumab | Herceptin |
19 | 2019 | Eticovo | Amgen | Etanercept | Enbrel |
20 | 2019 | Kanjinti | Roche | trastuzumab | Herceptin |
21 | 2019 | Pfizer | Roche | Bevacizumab | Avastin |
US approval | Year of Approval | Biosilimar Brand | Company | Biomolecule | Reference Product |
Related Articles
- What is 351(k) biologics license application (BLA)?
- What is the difference between biosimilar and interchangeable biological products?
- What is the major difference between biosimilar and interchangeable biological products?
- What is Biologic License Application (BLA)?
- Adalimumab Biosimilar Litigation: Sandoz’s settlement with AbbVie
- AbbVie, Pfizer’s non-exlcusive licencing agreement for biosimilar Humira